piracetam has been researched along with Exanthema in 6 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Over last fifty years, intravenous (iv) phenytoin (PHT) loading dose has been the treatment of choice for patients with benzodiazepine-resistant convulsive status epilepticus and several guidelines recommended this treatment regimen with simultaneous iv diazepam." | 8.98 | Why we prefer levetiracetam over phenytoin for treatment of status epilepticus. ( Amantini, A; Campostrini, R; Giannasi, G; Giorgi, FS; Giovannelli, F; Nazerian, P; Paganini, M; Zaccara, G, 2018) |
| "All LEV-induced cADRs were mild skin rashes which occurred within 28 days of LEV exposure." | 5.43 | Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy. ( An, DM; Chen, JN; Hu, FY; Ren, JC; Wang, W; Zhou, D, 2016) |
| "Neonatal seizures are often refractory to treatment with initial antiseizure medications." | 5.40 | Levetiracetam-induced anaphylaxis in a neonate. ( Ariguloglu, EA; Koklu, E; Koklu, S, 2014) |
| "Levetiracetam was stopped and she improved after treatment with norepinephrine, antihistamines and corticosteroids." | 5.38 | Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine. ( Alkhotani, A; McLachlan, RS, 2012) |
| "Over last fifty years, intravenous (iv) phenytoin (PHT) loading dose has been the treatment of choice for patients with benzodiazepine-resistant convulsive status epilepticus and several guidelines recommended this treatment regimen with simultaneous iv diazepam." | 4.98 | Why we prefer levetiracetam over phenytoin for treatment of status epilepticus. ( Amantini, A; Campostrini, R; Giannasi, G; Giorgi, FS; Giovannelli, F; Nazerian, P; Paganini, M; Zaccara, G, 2018) |
| "All LEV-induced cADRs were mild skin rashes which occurred within 28 days of LEV exposure." | 1.43 | Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy. ( An, DM; Chen, JN; Hu, FY; Ren, JC; Wang, W; Zhou, D, 2016) |
| "Neonatal seizures are often refractory to treatment with initial antiseizure medications." | 1.40 | Levetiracetam-induced anaphylaxis in a neonate. ( Ariguloglu, EA; Koklu, E; Koklu, S, 2014) |
| "Levetiracetam was stopped and she improved after treatment with norepinephrine, antihistamines and corticosteroids." | 1.38 | Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine. ( Alkhotani, A; McLachlan, RS, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaccara, G | 1 |
| Giorgi, FS | 1 |
| Amantini, A | 1 |
| Giannasi, G | 1 |
| Campostrini, R | 1 |
| Giovannelli, F | 1 |
| Paganini, M | 1 |
| Nazerian, P | 1 |
| Koklu, E | 1 |
| Ariguloglu, EA | 1 |
| Koklu, S | 1 |
| Bhoi, SK | 1 |
| Kalita, J | 1 |
| Misra, UK | 1 |
| Hu, FY | 1 |
| Wang, W | 1 |
| Ren, JC | 1 |
| An, DM | 1 |
| Chen, JN | 1 |
| Zhou, D | 1 |
| Wang, XQ | 1 |
| Lang, SY | 1 |
| Shi, XB | 1 |
| Tian, HJ | 1 |
| Wang, RF | 1 |
| Yang, F | 1 |
| Alkhotani, A | 1 |
| McLachlan, RS | 1 |
2 reviews available for piracetam and Exanthema
| Article | Year |
|---|---|
Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
Topics: Administration, Cutaneous; Administration, Intravenous; Anticonvulsants; Exanthema; Humans; Infusion | 2018 |
Skin rash following levetiracetam.
Topics: Adult; Anticonvulsants; Exanthema; Female; Humans; Levetiracetam; Male; Piracetam; Seizures; Young A | 2016 |
4 other studies available for piracetam and Exanthema
| Article | Year |
|---|---|
Levetiracetam-induced anaphylaxis in a neonate.
Topics: Anaphylaxis; Anticonvulsants; Asphyxia Neonatorum; Contraindications; Drug Eruptions; Exanthema; Fac | 2014 |
Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy.
Topics: Adult; Anticonvulsants; Asian People; Child; China; Epilepsy; Exanthema; Female; Gene Frequency; Gen | 2016 |
Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Topics: Adolescent; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; Chi | 2010 |
Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine.
Topics: Adult; Angioedema; Anticonvulsants; Exanthema; Female; Humans; Lamotrigine; Levetiracetam; Phenytoin | 2012 |